Company Filing History:
2 out of 321 
2 out of 4 Years Active: 2014-2015
Title: Innovator in Autoimmune Disease Treatment: The Contributions of Yun Ju Woo
Introduction: Yun Ju Woo, an accomplished inventor based in Seoul, South Korea, has made significant strides in the field of biomedical innovations. With a total of two patents to his name, his work primarily focuses on developing advanced therapies for autoimmune diseases, which continue to pose challenges in modern medicine.
Latest Patents: Among Yun Ju Woo's notable inventions are two groundbreaking patents aimed at treating autoimmune diseases. The first patent introduces a dual antagonist for TNF-α and IL-21, leveraging a TNFR2-IL21R fusion protein. This innovative composition effectively reduces the secretion of inflammatory cytokines, boosts anti-inflammatory cytokines, and suppresses osteoclast differentiation more efficiently than single proteins like TNFR2-Fc and IL21R-Fc. Notably, it has demonstrated remarkable therapeutic effects on rheumatoid arthritis in a CIA mouse model by enhancing Treg cell expression, suggesting a promising avenue for therapeutic interventions in autoimmune conditions.
The second patent involves a TNFR2-TWEAKR fusion protein, acting as a dual antagonist to TNF-α and TWEAK, both implicated in autoimmune arthritis. This invention has shown to significantly diminish IL-17 secretion in Th17 cells while increasing IL-10 secretion from Treg cells, surpassing the efficacy of individual proteins. Like his first patent, this innovation has demonstrated exceptional treatment effects in animal models of arthritis, indicating its potential as a key active ingredient for the prevention and treatment of autoimmune diseases.
Career Highlights: Yun Ju Woo's career is marked by his relentless pursuit of innovative solutions to critical health issues. His academic endeavors and clinical research have established him as a leader in the fight against autoimmune diseases. His contributions have garnered attention from both the scientific community and pharmaceutical industries.
Collaborations: Throughout his career, Yun Ju Woo has collaborated with esteemed organizations, including the Korea Research Institute of Bioscience and Biotechnology and the Industry-Academic Cooperation Foundation. He has also worked closely with the Catholic University of Korea, where he has furthered research initiatives in biotechnology. Among his notable coworkers are Young Woo Park and Ki Won Jo, who have contributed to his research efforts.
Conclusion: Yun Ju Woo stands out as an inventor dedicated to addressing critical health challenges through innovation. His patents showcase his commitment to advancing treatment options for autoimmune diseases, reflecting his impact on both the scientific and medical communities. As research continues to evolve, his contributions may pave the way for future breakthroughs in the prevention and management of autoimmune conditions.